Insulin aspart, recombinant Subcutaneous and Livixil Pak
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Livixil Pak and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: lidocaine / prilocaine topical
Brand name: Emla, Emla Anesthetic Disc, Livixil Pak, AgonEaze, Prizopak, LiproZonePak, Medolor Pak, Anodyne LPT
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Lixisenatide
- Insulin aspart, recombinant Subcutaneous-Lixisenatide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Lixtraxen Injection
- Insulin aspart, recombinant Subcutaneous-LMD
- Insulin aspart, recombinant Subcutaneous-LMD Injection
- Insulin aspart, recombinant Subcutaneous-LMX 4 Topical application
- Livixil Pak-Insulin degludec
- Livixil Pak-Insulin Degludec (U-100) Prefilled Pens
- Livixil Pak-Insulin Degludec (U-100) Vials
- Livixil Pak-Insulin Degludec (U-200) Prefilled Pens
- Livixil Pak-Insulin degludec and liraglutide
- Livixil Pak-Insulin degludec and liraglutide Subcutaneous